| 000 | 01109 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250518083328.0 | ||
| 264 | 0 | _c20201008 | |
| 008 | 202010s 0 0 eng d | ||
| 022 | _a1538-3598 | ||
| 024 | 7 |
_a10.1001/jama.2019.21428 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aResneck, Jack S | |
| 245 | 0 | 0 |
_aRefocusing Medication Prior Authorization on Its Intended Purpose. _h[electronic resource] |
| 260 |
_bJAMA _cFeb 2020 |
||
| 300 |
_a703-704 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aContinuity of Patient Care |
| 650 | 0 | 4 | _aCost Control |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aDrug Utilization Review |
| 650 | 0 | 4 | _aElectronic Health Records |
| 650 | 0 | 4 | _aFormularies as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMedicare Part D _xstatistics & numerical data |
| 650 | 0 | 4 |
_aPrescription Drugs _xeconomics |
| 650 | 0 | 4 |
_aPrior Authorization _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aUnited States |
| 773 | 0 |
_tJAMA _gvol. 323 _gno. 8 _gp. 703-704 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.2019.21428 _zAvailable from publisher's website |
| 999 |
_c30589561 _d30589561 |
||